BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raineri A, Fasoli S, Campagnari R, Gotte G, Menegazzi M. Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability. Int J Mol Sci 2019;20:E5980. [PMID: 31783660 DOI: 10.3390/ijms20235980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Castro J, Ribó M, Vilanova M, Benito A. Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents. Pharmaceutics 2021;13:82. [PMID: 33435285 DOI: 10.3390/pharmaceutics13010082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhai Z, Samson JM, Yamauchi T, Vaddi PK, Matsumoto Y, Dinarello CA, Ravindran Menon D, Fujita M. Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma. Cancers (Basel) 2020;12:E2518. [PMID: 32899791 DOI: 10.3390/cancers12092518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Montioli R, Campagnari R, Fasoli S, Fagagnini A, Caloiu A, Smania M, Menegazzi M, Gotte G. RNase A Domain-Swapped Dimers Produced Through Different Methods: Structure-Catalytic Properties and Antitumor Activity. Life (Basel) 2021;11:168. [PMID: 33669993 DOI: 10.3390/life11020168] [Reference Citation Analysis]
4 Gotte G, Campagnari R, Loreto D, Bettin I, Calzetti F, Menegazzi M, Merlino A. The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme. Int J Biol Macromol 2021;191:560-71. [PMID: 34563576 DOI: 10.1016/j.ijbiomac.2021.09.095] [Reference Citation Analysis]
5 Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor. Int J Cancer 2021;149:657-74. [PMID: 33837564 DOI: 10.1002/ijc.33591] [Reference Citation Analysis]
6 Kupczyk P, Simiczyjew A, Marczuk J, Dratkiewicz E, Beberok A, Rok J, Pieniazek M, Biecek P, Nevozhay D, Slowikowski B, Chodaczek G, Wrzesniok D, Nowak D, Donizy P. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study. Cells 2021;10:286. [PMID: 33572647 DOI: 10.3390/cells10020286] [Reference Citation Analysis]